6.17
+3.81(+161.44%)
Currency In USD
Address
20 Park Plaza
Boston, MA 02116
United States of America
Phone
617-744-4400
Website
Sector
Healthcare
Industry
Biotechnology
Employees
8
First IPO Date
May 23, 2008
| Name | Title | Pay | Year Born |
| Dr. John J. Alam M.D. | Co-Founder, Chief Executive Officer, President & Director | 680,255 | 1962 |
| Dr. Sylvie L. Gregoire Pharm.D. | Co-Founder & Director | 352,432 | 1961 |
| Dr. Robert J. Cobuzzi Jr., Ph.D. | Chief Operating Officer & Director | 386,600 | 1965 |
| Ms. Kelly Blackburn M.H.A. | Senior Vice President of Clinical Development | 404,940 | 1964 |
| Mr. William Robert Elder J.D. | Chief Financial Officer & General Counsel | 407,553 | 1983 |
| Dr. Claudia Ordonez M.D. | Senior Vice President of Medical Science | 0 | 1966 |
| Dr. Mark A. De Rosch Ph.D. | SVice President of Regulatory & Government Affairs & Program Management | 0 | 1963 |
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.